GlaxoSmithKline Pharmaceuticals Limited (BOM:500660)
India flag India · Delayed Price · Currency is INR
2,593.90
-73.05 (-2.74%)
At close: Feb 13, 2026

BOM:500660 Balance Sheet

Millions INR. Fiscal year is Apr - Mar.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Dec '25 Mar '25 Mar '24 Mar '23 Mar '22 Mar '21
Cash & Equivalents
-5,388641.71349.412,8624,052
Short-Term Investments
-8,4109,79411,00921,7917,320
Trading Asset Securities
-11,1828,1325,1833,656-
Cash & Short-Term Investments
20,60924,98118,56816,54128,30911,372
Cash Growth
-2.36%34.54%12.25%-41.57%148.94%7.10%
Accounts Receivable
-2,9252,2211,9242,0522,156
Other Receivables
-682.81,2751,373715.31254
Receivables
-3,6083,4963,2972,7682,410
Inventory
-4,8175,2504,6005,3475,467
Prepaid Expenses
-188.86206.18149.6139.26146.49
Other Current Assets
-503.25463.33355.04517.622,631
Total Current Assets
-34,09927,98424,94337,08022,026
Property, Plant & Equipment
-2,8393,1073,1513,2543,554
Long-Term Investments
-0.270.270.270.150.15
Other Intangible Assets
-133.32235.54340.91344.97433.64
Long-Term Deferred Tax Assets
-1,4091,4631,3351,1311,031
Other Long-Term Assets
-2,6012,7762,7952,6214,101
Total Assets
-41,08135,56633,26646,33331,146
Accounts Payable
-7,0826,2544,2785,7934,661
Accrued Expenses
-2,2151,6551,4824,6222,066
Current Portion of Long-Term Debt
-----0.24
Current Portion of Leases
-74.59121.96120.84124.53143.53
Current Income Taxes Payable
-5,2452,9862,9622,9621,637
Current Unearned Revenue
-----1,800
Other Current Liabilities
-4,4344,2334,4213,4833,238
Total Current Liabilities
-19,05215,24913,26416,98413,546
Long-Term Leases
-24.9264.6934.5576.24202.5
Pension & Post-Retirement Benefits
-868.04802.99793.71794.7798.42
Other Long-Term Liabilities
-1,6231,6731,7611,8481,817
Total Liabilities
-21,56817,79015,85319,70316,364
Common Stock
-1,6941,6941,6941,6941,694
Retained Earnings
-18,37116,54915,92025,21013,345
Comprehensive Income & Other
--552.3-467.04-201.58-274.96-256.9
Shareholders' Equity
17,07719,51317,77617,41326,63014,783
Total Liabilities & Equity
-41,08135,56633,26646,33331,146
Total Debt
357.199.51186.65155.39200.77346.27
Net Cash (Debt)
20,25224,88218,38216,38628,10811,026
Net Cash Growth
-3.38%35.36%12.18%-41.70%154.93%8.10%
Net Cash Per Share
119.54146.88108.5196.73165.9265.08
Filing Date Shares Outstanding
169.41169.41169.41169.41169.41169.41
Total Common Shares Outstanding
169.41169.41169.41169.41169.41169.41
Working Capital
-15,04712,73511,67920,0968,481
Book Value Per Share
100.81115.19104.93102.79157.1987.26
Tangible Book Value
16,99519,38017,54117,07226,28514,349
Tangible Book Value Per Share
100.32114.40103.54100.77155.1684.70
Land
-373736.822.4922.49
Buildings
-1,1211,0991,0841,0411,022
Machinery
-4,4014,4894,2443,9373,915
Construction In Progress
-143.2139.3203.12305.02132.14
Source: S&P Global Market Intelligence. Standard template. Financial Sources.